Evaluating Pulmonary Artery Doppler in Mothers with Preeclampsia
Fetal Pulmonary Artery Doppler in Mothers with Preeclampsia for Detecting Neonatal Respiratory Distress
This study is trying to see how a special ultrasound test can help understand the lung health of babies in mothers with severe preeclampsia to make better decisions about when to deliver them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 41 (estimated) |
| Sex | Female |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Assiut) |
| Trial ID | NCT06755073 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the pulmonary artery Doppler parameters in fetuses of mothers diagnosed with severe preeclampsia. Preeclampsia is a significant public health issue affecting a notable percentage of pregnancies and is associated with fetal growth restriction. The study aims to assess the relationship between preeclampsia and fetal lung maturity, utilizing ultrasound techniques to gather data on fetal health. By understanding these parameters, the study seeks to inform clinical decisions regarding the timing of delivery in preeclamptic pregnancies.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women between 28 to 37 weeks gestation diagnosed with severe preeclampsia.
Not a fit: Patients who may not benefit from this study include those with fetal death, congenital anomalies, or fetal cardiac arrhythmias.
Why it matters
Potential benefit: If successful, this study could improve outcomes for fetuses in preeclamptic pregnancies by guiding timely interventions.
How similar studies have performed: While the approach of using pulmonary artery Doppler in this context is established, the specific application to severe preeclampsia and its implications for fetal outcomes is still being explored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * preeclampsia patients Pregnant 28 -37 weeks Exclusion Criteria: * fetal death Congenital fetal anomalies Fetal Cardiac arrhythmia
Where this trial is running
Assiut
- Women's Health Hospital — Assiut, Egypt (Recruiting)
Study contacts
- Study coordinator: Mohamed Fekry, PhD
- Email: mohamedbeethoven2040@gmail.com
- Phone: 0882312388
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.